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Inﬂammatory biomarkersAbstract The aim of this study was to investigate the effective role of silymarin either alone or in com-
binationwith chlorogenic acid and/ormelatonin against the toxic impact of carbon tetrachloride (CCl4)
induced cardiac infarction. CCl4 (l.2 ml/kg body weight) was administered as a single dose intraperito-
neally. The results revealed that the administrationof silymarin alone or in combinationwith chlorogen-
ic acid (CGA) and/or melatonin for 21 consecutive days, 24 h after CCl4 injection to rats, markedly
ameliorated the increases in serum markers of cardiac infarction, including troponin T and creatine
kinase-MB (CK-MB), as well as increases in the pro-inﬂammatory biomarkers, including interleukin-
6 (IL-6), interferon-c (IFN-c) in serum and tumor necrosis factor-a (TNF-a) and C-reactive protein
in cardiac tissue compared to CCl4 intoxicated rats. The used agents also successfully modulated the
alteration in vascular endothelial growth factor (VEGF) in serum and the oxidative DNA damage
and the increase in the apoptosis marker caspase 3 in cardiac tissue in response to CCl4 toxicity. The
present biochemical results are supported byhisto-pathological examination.The current results proved
that treatment with silymarin in combination with CGA and melatonin was the most effective one in
ameliorating the toxicity of CCl4 induced cardiac damage and this may support the use of this combi-
nation as an effective drug to treat cardiac damage induced by toxic agents.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Carbon tetrachloride (CCl4) is a xenobiotic hazardous hepato-
toxin (Xiao et al., 2012). But in addition to hepatic damage, it
also causes disorders in tissues other than liver including heart
by generating free radicals (Ozturk et al., 2003; Jayakumara
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rapidly causes cellular necrosis, oxidative stress and inﬂamma-
tion which leads to acute tissue injury and apoptotic organ fail-
ure (Karakus et al., 2011; Shi et al., 2012). The toxicity of CCl4
resulting from increased free radical production may play an
important role in degenerative processes in the tissues. The
toxicity of CCl4 includes two steps. The ﬁrst one is the produc-
tion of free radicals (CCl3* and CCl3OO*) through the metab-
olism of NADPH – cytochrome P450 system, which induces
lipid peroxidation. The second phase involves the activation
of tissue macrophages which is accompanied by the production
of inﬂammatory and proﬁbrogenic mediators (Shi et al., 2012).
Maintaining the balance between free radicals and antioxi-
dants is therefore important as well as inhibiting inﬂammatory
mediators may serve as major mechanisms in preventing dam-
age impact induced by toxic agents. The implication of oxida-
tive stress and inﬂammation in the etiology and progression of
several acute and chronic clinical disorders has led to the sug-
gestion that agents with antioxidant and anti-inﬂammatory
properties may have health beneﬁts. Several antioxidant
agents, including silymarin, antioxidant vitamins (C and E),
and melatonin have been reported to reduce CCl4-induced tox-
icity (Donder et al., 1999; Turkdogan et al., 2001; Shaker et al.,
2011).
Silymarin is an active extract isolated from the milk thistle
plant Silybum marianum. Silymarin consists of a mixture of
three bioﬂavonoids found in the fruit, seeds and leaves of the
plant: silybin, silydianin and silychristin (Pepping, 1999). Sily-
bin is the main component (60–70%) and is believed to have
the most biological activity. Silymarin has been shown to have
potential impact in many liver disorders, including oxidative
stress, injury and ﬁbrosis induced by CCl4 (Shaker et al.,
2011). It also has protective effect against reperfusion-induced
myocardial infarction in rats (Rao and Viswanath, 2007).
Silymarin can prevent lipid peroxidation, inhibit low-density
lipoprotein oxidation and scavenge reactive oxygen species
(Post-White et al., 2007). Silymarin also has anti-inﬂammatory
effects which may relate its ability to inhibit the transcription
factor nuclear factor-kB (NF-kB), which contributes to the
production of proinﬂammatory mediators such as interleukin
(IL)-1 and IL -6, TNF-a, lymphotoxin, granulocyte macro-
phage, colony-stimulating factor (GM-CSF) and interferon
(IFN)-c (Deep and Agarwal, 2007).
Chlorogenic acid (CGA) is a type of polyphenol and is
found in many foods, including coffee, berries, potatoes, car-
rots, wine, apples, and various herbs (Stoclet et al., 2004). It
has many pharmacological activities as anti-inﬂammatory,
antidiabetic, antitumor and antiulcerogenic actions. (Feng
et al., 2005; Kim et al. 2011; Shimoyama et al., 2012; Yang
et al., 2012). A recent study showed that CGA can protect mice
from lipopolysaccharides (LPS) -induced hepatotoxicity or
lung injury (Xu et al., 2012; Zhang et al., 2010). Another study
showed that CGA can inhibit LPS-induced inﬂammatory cyto-
kines release in RAW264.7 cells (Shan et al., 2009). CGA can
also efﬁciently inhibit CCl4 induced liver ﬁbrosis in rats (Shi
et al., 2012). It has the ability to regulate cytokine and chemo-
kine release, suppress cellular apoptosis and has protective
beneﬁcial effect against the injury of different organs including
heart in murine sepsis (Lee et al., 2012).
Melatonin (N-acetyl-5-methoxytryptamine) is formed
mainly in the pineal gland of most mammals including man.
This hormone has important functions. It is a powerfulanti-inﬂammatory, anti-apoptosis, free radical scavenger and
broad-spectrum antioxidant which has been tested in previous
experimental studies (Zhaoa et al., 2008; Cuesta et al., 2011).
Melatonin also was reported to have protective impact on
myocardial infarction (Chen et al., 2003). The anti-inﬂamma-
tory activity of melatonin was reported through the inhibition
of NF-jB (Alonso et al., 2006) which is known to be one of the
crucial transcription factors required for maximal transcrip-
tion of a wide array of pro-inﬂammatory molecules, including
TNF-a, IL-1b, IL-6 and other mediators (Ali and Mann,
2004). It also has a protective action against oxidative DNA
damage (Zhaoa et al., 2008).
This study was designed to investigate the potential impact
of silymarin either alone or in combination with CGA and/or
melatonin on cardiac damage induced by inﬂammation, oxida-
tive DNA damage and apoptosis in response to CCl4 toxicity
in rats.
2. Materials and methods
2.1. Chemicals
All chemicals used were of high analytical grade, product of
Sigma and Merck companies. Silymarin, chlorogenic acid
and melatonin were purchased from Sigma Chemical Co. (Sig-
ma, St. Louis, MO, USA).
2.2. Animals and treatments
Animal experiments were performed with approval from the
local ethics committee. Sixty healthy male albino rats (120–
150 g) were supplied by the Experimental Animal Center, Col-
lege of Pharmacy, King Saud University. Animals were kept in
special cages and maintained on a constant 12-h light/12-h
dark cycle with air conditioning and a controlled temperature
of 20–22 C and humidity of 60%. Rats were fed a standard
rat pellet chow with free access to tap water ad libitum for
1 week before the experiment for acclimatization. Animal uti-
lization protocols were performed in accordance with the
guidelines provided by the Experimental Animal Laboratory
and approved by the Animal Care and Use Committee of
the College of Pharmacy, King Saud University. After 1 week
of acclimation, the rats were fasted overnight before treatment
and randomly divided into six groups, each of ten rats as
follows.
 Group 1: Normal healthy animals (not receiving any
medication).
 Group2: CCl4-intoxicated animals.
 Group3: CCl4 intoxicated animals and treated with
silymarin.
 Group 4: CCl4 intoxicated animals and treated with
silymarin and CGA.
 Group 5: CCl4 intoxicated animals and treated with
silymarin and melatonin.
 Group 6: CCl4 intoxicated animals and treated with a
combination of silymarin, CGA and melatonin.
CCl4 was administered to the rats intraperitoneally as a
mixture of CCl4 and corn oil (1:1, 1 ml/kg body weight;
0.5 ml/kg body weight as CCl4, Yachi et al., 2010). Silymarin
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et al., 2009) and melatonin (20 mg/kg/day, Laliena et al.,
2012) were dissolved in gum acacia (2% w/v) and given orally
once daily for 21 successive days, 24 h post CCl4 injection.
After the experimental period, blood samples were collected
from each animal in all groups into sterilized tubes for serum
separation. Serum was separated by centrifugation at
3000 rpm for 10 min and used for biochemical serum analysis.
After blood collection, the rats of each group were sacriﬁced
under ether anesthesia, and their hearts were collected,
weighed and washed using chilled saline solution. The hearts
were minced and homogenized in ice-cold bi-distilled water
to yield 10% homogenates. The homogenates were centrifuged
for 15 min at 4000 rpm at 4 C, and the supernatants were used
for biochemical tissue analysis. Four hearts from each group
were kept in 10% formalin for histo-pathological examination.
2.3. Biochemical serum analysis
Troponin T concentration was determined using a Siemens
Dimension Xpand Plus instrument (IL, USA). Creatine ki-
nase-MB (CK-MB) was estimated spectrophotometrically
using a standard enzyme kit supplied by Spinreact, S.A.-Spain
(Cat.No.1001055). The concentration of InF-c and IL-6 was
determined by enzyme-linked immunosorbent assay (ELISA)
kits (R&D ELISA Kit, USA) following the manufacturer’s
instructions. The level of vascular endothelial growth factor
(VEGF) was determined at 492 nm by quantitative colorimet-
ric sandwich enzyme-linked immunosorbent assay (ELISA;
R&D Systems, UK) in accordance with the manufacturer’s
instructions. Concentrations were calculated using a standard
curve generated with speciﬁc standards provided by the
manufacturer.
2.4. Biochemical assay of heart tissue
The concentration of TNF-a was determined using commer-
cially available ELISA assays following the instructions sup-
plied by the manufacturer (DuoSet kits; R&D Systems,
Minneapolis, MN, USA). CRP was measured with latex-en-
hanced immunonephelometry on a Behring BN II Nephelom-
eter (Dade Behring). In this assay, polystyrene beads coated
with rat monoclonal antibodies bind CRP present in the sam-
ple and form aggregates. The intensity of the scattered light is
proportional to the size of the aggregates and thus reﬂects the
concentration of CRP present in the sample. The intra-assay
and inter-assay coefﬁcients of variation for CRP were 3.3%
and 3.2%, respectively. The lower detection limit of the assay
was 0.15 mg/L.
2.4.1. Assay of caspase 3 activity
Caspase-3-like protease was assayed according to the method
described by Vaculova and Zhivotovsky (2008).
2.4.2. Comet assay
The comet assay, or single cell gel electrophoresis, is a widely
used technique for measuring and analyzing DNA breakage
in individual cells. The method of Singh et al. (1988), which in-
volves the unwinding of DNA under alkaline conditions, was
used in this study. At least ﬁfty cells per sample were submittedto analysis. The parameters measured to analyze the electro-
phoretic patterns were the tail length as measured from the
middle of the head to the end of the tail, tail moment and
the relative DNA content in the tail. The tail moment was de-
ﬁned by the percentage of DNA in the tail multiplied by the
length between the center of the head and tail which was de-
ﬁned by Olive et al. (1990).
2.5. Histopathological examination
Small pieces of heart were ﬁxed by 4% formalin and then
embedded into parafﬁn, sectioned for 5–6-lm thickness, and
mounted on glass microscopic slides using standard histopa-
thological technique. The sections were stained with hematox-
ylin-eosin and examined by light microscopy.
2.6. Statistical analysis
Data were analyzed by comparing values for different treat-
ment groups with the values for individual controls. Results
are expressed as mean ± SE. Signiﬁcant differences among
values were analyzed using one-way analysis of variance (AN-
OVA) followed by Bonferroni’s test.
3. Results
Serum cardiac biomarkers, namely troponin T and CK-MB, in
the normal and different experimental groups intoxicated with
CCl4 are shown in Table 1. The toxicity of CCl4 induced pro-
nounced increases in these biomarkers compared with normal
animals (P 6 0.001), and the intake of either silymarin alone or
in combination with CGA and/or melatonin signiﬁcantly
down-modulated the deviation in these markers versus CCl4
intoxicated group.
The levels of some immunological pro-inﬂammatory bio-
markers, including InF-c and IL-6 in sera and TNF-a and
CRP in cardiac tissue in the normal and different experimental
groups intoxicated with CCl4 are illustrated in Tables 2 and 3,
respectively. These biomarkers were dramatically elevated in
rats intoxicated with CCl4 compared with the normal ones
(P 6 0.001). The intake of the studied agents 24 h after CCl4
injection for 21 consecutive days, markedly inhibited the in-
duced inﬂammatory mediators compared with intoxicated
animals.
The level of VEGF (angiogenic factor) signiﬁcantly in-
creased in the sera of rats intoxicated with CCl4 compared
with normal animals (Table 2). Administration of silymarin
alone or in combination with CGA and/or melatonin, mark-
edly reduced the dramatic increase in this biomarker in the sera
of CCl4-intoxicated rats compared with intoxicated untreated
animals (P 6 0.001).
The effect of the administration of CCl4 on cardiac DNA of
rats is shown in Table 4 and Fig. 1. A signiﬁcant increase in the
tail length, DNA% (tail DNA content) and tail moment was
shown in the cardiac tissue of rats intoxicated with CCl4.
Administration of the current agents in CCl4-intoxicated rats
signiﬁcantly mitigated their cardiac tissue from DNA damage
as indicated by a decrease in the above markers of DNA dam-
age compared with intoxicated untreated rats (P 6 0.001).
Table 4 also shows that the cardiac apoptosis biomarker cas-
pase 3 was signiﬁcantly up-regulated in rats administered
Table 1 Effect of silymarin alone or in combination with CGA and/or melatonin treatment on serum markers of cardiac infarction in
rats intoxicated with CCl4.
Parameter CK-MB (U/L) Trponine T (Pg/ml)
Control 34.84 ± 1.19 21.66 ± 1.14
CCL4 100.7 ± 2.38
a 41.22 ± 1.17a
CCl4 + Silymarin 59.70 ± .43b* 37.93 ± 0.67a**
CCl4 + Silymarin + CGA 53.74 ± 2.17b*$$ 30.59 ± 0.44b*$$
CCl4 + Silymarin +Melatonin 54.65 ± 1.73b*$$ 31.03 ± 0.45b*$$
CCl4 + Silymarin + CGA+Melatonin 40.53 ± .87b*$ 25.65 ± 1.60b*$
Data are presented as mean ± SD of 6 rats.
a P 6 0.001 compared with the normal group.
b P 6 0.01 compared with the normal group.* P 6 0.001 compared with the CCl4-intoxicated group.
** P 6 0.05 compared with the CCl4-intoxicated group.
$ P 6 0.01 compared with the silymarin group, using ANOVA followed by the Bonferroni’s test.
$$ P 6 0.05 compared with the silymarin group, using ANOVA followed by the Bonferroni’s test.
Table 2 Effect of silymarin either alone or in combination with CGA and/or melatonin on the levels of serum inﬂammatory and
angiogenic markers in CCl4 intoxicated rats.
Groups InF-c (pg/ml) IL-6 (pg/ml) VEGF (Pg/ml)
Control 1.79 ± .081 12.92 ± 0.83 1.66 ± .053
CCL4 3.57 ± .07
a 42.31 ± 2.10a 2.9 ± .088a
CCl4 + Silymarin 2.3 ± .06b* 31.92 ± 0.52a* 1.89 ± .016b*
CCl4 + Silymarin + CGA 2.02 ± .04c*$ 21.98 ± 0.52b*$ 1.82 ± .024b*$$
CCl4 + Silymarin +Melatonin 2.01 ± .02c*$ 20.53 ± 1.1b*$ 1.80 ± .02b*$$
CCl4 + Silymarin + CGA+Melatonin 1.81 ± .05*$ 13.28 ± 0.7*$ 1.69 ± .028*$
Data are presented as mean ± SD of 6 rats.
a P 6 0.001 compared with the normal group.
b P 6 0.01 compared with the normal group.
c P 6 0.05 compared with the normal group.
* P 6 0.001 compared with the CCl4-intoxicated group.
$ P 6 0.01 compared with silymarin group, using ANOVA followed by the Bonferroni’s test.
$$ P 6 0.05 compared with silymarin group, using ANOVA followed by the Bonferroni’s test.
Table 3 Effect of silymarin either alone or in combination with CGA and/or melatonin on levels of inﬂammatory markers in cardiac
of CCl4 intoxicated rats.
Groups TNFa (pg/100 mg) CRP (ng/100 mg)
Control 50.34 ± 0.98 6.97 ± 0.13
CCL4 93.84 ± 1.47
a 12.67 ± 0.58
CCl4 + Silymarin 65.82 ± 0.87c* 9.80 ± 0.15b*
CCl4 + Silymarin + CGA. 58.32 ± 1.15c*$$ 8.72 ± 0.2c*$
CCl4 + Silymarin +Melatonin 56.93 ± 0.49c*$$ 8.60 ± 0.6c*$
CCl4 + Silymarin + CGA+Melatonin 50.8 ± .20*$ 7.2 ± 0.3*$$
Data are presented as mean ± SD of 6 rats.
a P 6 0.001 compared with the normal group.
b P 6 0.01 compared with the normal group.
c P 6 0.05 compared with the normal group.
* P 6 0.001 compared with the CCl4-intoxicated group.
$ P 6 0.01 compared with sil group, using ANOVA followed by the Bonferroni’s test post-ANOVA.
$$ P 6 0.05 compared with sil group, using ANOVA followed by the Bonferroni’s test post-ANOVA.
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rats beneﬁcially down-modulated the increase in cardiac cas-
pase 3 in relation to intoxicated rats (P 6 0.001).
The myocardial structure of normal and different groups of
CCl4 intoxicated rats was examined by H&E staining
(Fig. 2A–F) and masson’s trichrome (Fig. 3A–F) staining
respectively. Normal untreated rats showed normal cardiac
ﬁbers (Fig. 2A) and normal collagen ﬁbers (Fig. 3A).Myocardial damage induced by CCl4 is observed by focal
areas with massive degeneration (Fig. 2B) and scattered areas
of ﬁbrosis stained in blue (Fig. 3B). Administration of silyma-
rin 24 h post CCl4 injection showed mild improvement in the
cardiac histological picture (Fig. 2C) and few areas of ﬁbrosis
(Fig. 3C). Administration of silymarin either with CGA
(Fig. 2D and Fig. 3D) or melatonin (Fig. 2E and Fig. 3E)
showing few scattered areas of little degeneration and collagen
Table 4 Effect of silymarin alone or in combination with CGA and/or melatonin on markers of DNA damage using the comet assay
and the apoptosis marker, caspase-3 in the cardiac tissues of CCl4 intoxicated rats.
Groups Tail length (lm) DNA% in tail Unit tail moment Caspas-3
Control 1.41 ± 0.039 1.88 ± 0.094 1.41 ± 0.19 86.32 ± 1.91
CCL4 4.42 ± 0.15
a 3.82 ± 0.08a 4.8 ± .15a 182 ± 3.12a
CCl4 + Silymarin 2.92 ± 0.06a* 2.93 ± 0.06b* 2.72 ± 0.06b* 94.41 ± .98b*
CCl4 + Silymarin + CGA. 2.5 ± 0.03a*$ 2.44 ± 0.05b*$ 2.18 ± 0.024b*$ 90.79 ± 1.23*
CCl4 + Silymarin +Melatonin 2.4 ± 0.04a*$ 2.29 ± 0.15b*$ 2.05 ± 0.03b*$ 89.99 ± .92*$
CCl4 + Silymarin + CGA+Melatonin 1.48 ± 0.05*$$ 1.92 ± 0.02*$$ 1.54 ± .05*$$ 86.49 ± 1.01b*$
Data are presented as mean ± SD of 6 rats.
a P 6 0.001 compared with the normal group.
b P 6 0.01 compared with the normal group.
* P 6 0.001 compared with the CCl4-intoxicated group.
$ P 6 0.05 compared with the silymarin group, using ANOVA followed by the Bonferroni’s test.
$$ P 6 0.01 compared with the silymarin group, using ANOVA followed by the Bonferroni’s test.
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the three agents showing more or less normal cardiac tissue
(Fig. 2F) and normal collagen distribution within cardiac tis-
sue (Fig. 3F).
From the current results, it can observed that ingestion of
the combination of silymarin, CGA and melatonin to CCl4
intoxicated rats was the most effective one in modulating the
deviation in studied biochemical biomarkers and histomorpho-
logical pictures of cardiomyopathy compared with silymarin
alone or in combination with either CGA or melatonin .
4. Discussion
The current study revealed that CCl4 injection to rats induced
cardiotoxicity as indicated by elevations in serum cardiac dam-
age biomarkers, namely troponin T and CPK-MB. Troponins
regulate the calcium-mediated interaction between actin and
myosin (Adamcova et al., 1997). Most intracellular troponin
T is bound to the myobrils in the cardiac myocyte; however,
a small percentage exists in a cytosolic pool (Kemp et al.,
2004). The importance of this pool is as the source of cytosolic
troponins released 4–6 h after myocardial injury. Continuing
breakdown of the myobrils in damaged myocytes results in
the prolonged elevation of the concentration of troponin T
in blood (Maynard et al., 2000). Troponin T and CK-MB
are released by damaged heart tissues and are frequently used
as diagnostic markers for predicting adverse cardiovascular
events, such as death or myocardial infarction (Kemp et al.,
2004; Santos et al., 2011).
Administration of silymarin only or in combination with
CGA and/or melatonin to CCl4 intoxicated rats markedly re-
duced the serum biomarkers of myocardial infarction com-
pared with intoxicated rats. The combination of the three
agents was the most effective one. This result may predict
the beneﬁcial role of these agents in protection against myocar-
dial injury induced by CCl4 toxicity. This good impact of the
studied agents against tissue damage induced by toxic agents
was previously documented in experimental animal models
(Chlopcı´kova´ et al., 2004; Rao and Viswanath, 2007; Domin-
guez-Rodriguez et al., 2012).
The present study also showed marked increases in immu-
nological pro-inﬂammatory biomarkers, including InF-c and
IL-6, in rat sera intoxicated with CCl4 accompanied withincreases in TNF-a and CRP in their cardiac tissue compared
with the normal group. The increase in the inﬂammatory cyto-
kines by CCl4 may be related to the activation of nuclear fac-
tor-kB which contributes to the production of inﬂammatory
cytokines (Li et al., 2012a). The induction of such biomarkers
may play a principle role in cardiac infarction and dysfunction
induced by CCl4 toxicity. This is supported by previous study
which reported that TNF-a is implicated in the pathophysiol-
ogy of myocardial failure (Irwin et al., 1999). The up-regula-
tion of this cytokine promotes the production of other
cytokines and IL-6, the chief stimulator of the production of
CRP, inducing inﬂammatory heart disease (De Ferranti and
Rifai, 2007). IL-6 triggers the activation of transcription fac-
tors that bind to DNA elements and stimulate increased tran-
scription of CRP, resulting in a rise in its level (Patel et al.,
2007).
Thus, a protective strategy that attenuates the production
of inﬂammatory mediators could predispose to remote organ
dysfunction.
Intake of silymarin alone or in combination with CGA and/
or melatonin to CCl4 intoxicated rats, effectively ameliorated
the increases in the inﬂammatory immunological biomarkers,
InF-c and IL-6 in sera, as well as TNF-a and CRP in cardiac
tissue of CCl4 intoxicated rats, suggesting that their cardiopro-
tective effect against myocardial infarction may be related to
their anti-inﬂammatory and immunomodulatory beneﬁcial ac-
tions. Treatment with the silymarin in combination with CGA
and melatonin was the most inﬂuential one in reducing the lev-
els of these markers .The immunomodulatory and the anti-
inﬂammatory actions of silymarin, CGA or melatonin were
previously proven through inhibiting nuclear factor-kappa B
(NF-kB) action which is known to be one of the critical tran-
scription factors required for maximal transcription of a wide
array of pro-inﬂammatory molecules, including TNF-a, IL-1b,
IL-6 and other mediators (Ali and Mann, 2004; Feng et al.,
2005; Polyak et al., 2007). Also, CGA was found to have the
ability to attenuate the increases in these inﬂammatory cyto-
kines in sera of CCl4- intoxicated rats (Shi et al., 2012).
The present study also demonstrated a signiﬁcant increase
in the angiogenic factor VEGF in the sera of rats intoxicated
with CCl4. The increase in this angiogenic factor was docu-
mented in response to CCl4 toxicity by some authors (Shi
et al., 2009). Previous data stated that the expression of various
Figure 1 DNA damage in the cardiac tissues of CCl4 intoxicated rats and the effect of silymarin alone or in combination with CGA and/
or melatonin treatment on the level of DNA damage. Comet assay showing the degree of DNA damage in the cardiac tissues of (A)
normal control group, (B) group intoxicated with the CCl4, (C) intoxicated group treated with silymarin, (D) intoxicated group treated
with silymarin and CGA (E) intoxicated group treated with silymarin and melatonin, (F) intoxicated group treated with a combination of
silymarin, CGA and melatonin.
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late VEGF synthesizing cells such as platelets, immune cells,
and inﬂammatory cells (Verheul et al., 2000; Lingen, 2001).
It is a part of the system that restores the oxygen supply to tis-
sues when blood circulation is inadequate (Prior et al., 2004).
However, other studies stated that TNF-a and VEGF expres-
sions were signiﬁcantly linked. Both TNF-a and VEGF may
promote a procoagulant state by increasing the expression of
tissue factors on endothelial cells and/or monocytes (Clauss
et al., 1996; Mechtcheriakova et al., 2001). Increased tissue fac-
tor expression is thought to play a signiﬁcant role in the devel-
opment of multi-organ system failure in acute injury
(Mechtcheriakova et al., 2001). The current result may suggest
the possibility of TNF-a and VEGF synergistically to potenti-
ate cardiac infarction and/or systemic organ dysfunction.
Ingestion of silymarin alone or in combination with CGA
and/or melatonin markedly reduced the dramatic increase inthis angiogenic biomarker in the sera of CCl4-intoxicated rats.
The three agents were synergistically beneﬁcial in attenuating
this marker, suggesting their anti-angiogenic potential action.
The angio-preventive beneﬁcial effect of these agents was also
proved by some studies (Shi et al., 2009; Park et al., 2010; Deep
et al., 2012).
The damaging effect of CCl4 on DNA has been shown in
previous studies (Iwai et al., 2002; Makni et al., 2012). The co-
met assay is a sensitive and a simple assay for detecting DNA
damage at the level of individual cells (Singh et al., 1988).
Increased DNA migration accompanies the DNA fragmen-
tation associated with the cell death arising from a non- DNA-
mediated process or apoptosis (Tice and Strauss, 1995). With
an increasing number of breaks, DNA pieces migrate freely
into the tail of the comet, and in extreme cases (the apoptotic
cell), the head and the tail are well separated. Tail length,
percentage of total DNA in the tail and tail -DNA moment,
Figure 2 Light photomicrograph of rat cardiac stained with H&E; scale bar = 100 lm in which (A) is normal myocardium, (B) CCl4
intoxicated rats, showing focal areas with massive degeneration (star), (C) CCl4 intoxicated rats and received silymarin showing marked
improvement of myocardial degeneration (arrow), (D) CCl4 intoxicated rats that received both silymarin and CGA, showing few areas of
little degeneration (arrow), (E) CCl4 intoxicated rats that received silymarin and melatonin showing few areas of little degeneration
(arrow),while (F) CCl4 intoxicated rats that received a combination of silymarin, CGA and melatonin showing more or less normal
cardiac tissue.
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erally seems to be the most useful, as it is directly related to the
frequency of breaks over a wide range of damage (ColLins
et al., 1996).
As documented by some studies, the current study revealed
that CCl4 induced cardiac DNA damage as evidenced by a sig-
niﬁcant increase in the tail length, DNA% in the tail and tail -
DNA moment in cardiac of rats versus normal ones (Iwai
et al., 2002;Makni et al., 2012). Some studies demonstrated that
the over production of nitric oxide (NO) induced by inﬂamma-
tory cytokines in response to tissue injury has the major role in
DNA damage (Liu et al., 1996; Filep et al., 1997). Also, it was
found that, the increase of TNF-a level stimulated the produc-
tion of reactive oxygen species (ROS), which mediate DNA
damage, in cultured cardiac myocytes (Suematsu et al., 2003).
Adminsteration of silymarin alone or in combination with
CGA and/or melatonin to CCl4 -intoxicated rats, effectively
attenuated the deviation in the above markers of DNA dam-
age in their cardiac tissue. The combination of the three agents
was the potential one that ameliorated these markers to near
their normal levels. Recent study documented that silymarin
possesses substantial protective effect against DNA damageand apoptosis induced by the environmental pollutant ben-
zo(a)pyrene (Perumal Vijayaraman et al., 2012). Also, it was
proved that CGA and melatonin have DNA damage protec-
tive effects (Fischer et al., 2012; Xu et al., 2012).
Apoptosis represents a key event after oxidative DNA dam-
age (Sharma et al., 2009). In line with some investigators, the re-
sult in the present study revealed that CCl4 induced apoptosis in
cardiac muscles as shown by markedly increased activity of the
apoptosis biomarker caspase 3 in cardiac tissue of rats intoxi-
cated with CCl4, suggesting that apoptosis might contribute
to this toxin induced DNA damage (Karakus et al., 2011).
The intake of silymarin alone or in combination with CGA
and/or melatonin to CCl4 -intoxicated rats pronouncedly
down-modulated the increase in heart caspase 3. This result
may suggest that the beneﬁts of using agents in protecting car-
diomyopathy induced by CCl4 might be associated with their
strong anti-apoptotic impact. The mechanism of their antiap-
optotic effect may be related to their ability to prohibit
DNA damage induced by CCl4. This result in accordance with
Patel et al. (2010) who documented that silymarin reduced
apoptotic cell death associated with hepatotoxicity. CGA can
also suppress cellular apoptosis (Cho et al., 2009). Besides,
Figure 3 Light photomicrograph of rat cardiac stained with Masson’s trichrome; scale bar = 100 lm in which (A) showing normal
perivascular collagen ﬁbers (arrow), (B) cardiac of CCl4 intoxicated rats showing scattered areas of ﬁbrosis stained in blue (arrow), (C)
cardiac of CCl4 intoxicated rats that received silymarin modulated cardiac ﬁbrosis as shown by few areas of collagen deposition (arrow),
(D and E) CCl4 intoxicated rats that received both silymarin with either CGA or melatonin respectively, showing a marked decrease in
collagen deposition (arrow), (F) CCl4 intoxicated rats that received a combination of silymarin, CGA and melatonin showing apparently
normal collagen distribution within the cardiac tissue.
272 N.M. Al-Rasheed et al.melatonin can diminish apoptosis of the liver after ischemia/
reperfusion (Kireev et al., 2012).
The biochemical results of the current study were supported
by histopathological observations. The damaging effect of
CCl4 on cardiac tissue was observed in histomorphologic pic-
tures by focal areas with great degeneration and excess colla-
gen accumulation. Similar observation was supported by Li
et al. (2012b). Administration of silymarin alone showed mild
improvement which was more evident on the administration of
silymarin with either CGA or melatonin. However ingestion of
the combination of the three agents was the most effective one
in modulating the histomorphologic picture of cardiac to more
or less normal. The modulating effect of the used agents on
collagen deposition may indicate the anti- ﬁbrotic beneﬁt of
the used agents which was documented by previous studies
(Kim et al., 2012; Li et al., 2012b; Shi et al., 2012).
In conclusion, the present ﬁndings showed that although
silymarin alone or in combination with either CGA or melato-
nin was beneﬁcial in ameliorating the inﬂammatory response-
induced cardiac infarction as well as oxidative DNA damage
and apoptosis caused by the toxic effects of CCl4, the combi-
nation of the three agents was the most effective one and thismay support the use of this combination as an effective drug to
treat cardiomyopathy.Acknowledgments
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